drugset / Trial / NCT02183233
Efficacy and Safety of Eschscholtzia Californica in Treating Primary Insomnia
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this trial was to assess the efficacy and safety of Eschscholtzia Californica (EC) in treating patients having psycho-physiologic insomnia in a double-blind randomised placebo controlled trial during a 28-day treatment duration.
Timeline
- Start
- 1998-01
- Primary completion
- 1998-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eschscholtzia Californica | Unknown | 1000 mg | — |